Recent trials reveal promising advancements in targeted therapies for chondrosarcomas and tenosynovial giant cell tumors.
Neeta Somaiah, MD
Advertisement
Articles by Neeta Somaiah, MD
Neeta Somaiah, MD, discusses the expanding role of targeted therapies in patients with gastrointestinal stromal tumor and how these treatments are bolstering later lines of therapy.
Neeta Somaiah, MD, discusses new and upcoming targeted therapies for sarcomas at the Inaugural Miami Cancer Institute Precision Medicine Oncology Symposium.
Neeta Somaiah, MD, reviews the case of a 68-year-old man with gastrointestinal stromal tumor.
Neeta Somaiah, MD, discusses the evolution of treatment options for patients with a unique sarcoma.
Advertisement
Latest Updated Articles
Progressing Gastrointestinal Stromal TumorPublished: July 16th 2020 | Updated:
Treatment Options in Gastrointestinal Stromal TumorsPublished: July 16th 2020 | Updated:
Molecular Testing in Gastrointestinal Stromal TumorsPublished: July 16th 2020 | Updated:
Understanding the INVICTUS TrialPublished: July 16th 2020 | Updated:
Presentation of a Gastrointestinal Stromal Tumor CasePublished: July 16th 2020 | Updated:
Future Directions of Gastrointestinal Stomal TumorsPublished: July 16th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
Gemogenovatucel-T Triples Overall Survival in High-Risk HRP Ovarian Cancer
3
FDA Accepts NDA of Zanzalintinib Combo for Pretreated Metastatic CRC
4
FDA Grants Orphan Drug Designation to IFx-2.0 for Advanced Melanoma
5